Anemia in renal allograft recipients

Anemia in renal allograft recipients

The review deals with anemia, one of the posttransplantation complications. To define the ways of preventing this complication in the posttransplantation period, the factors favors its development are analyzed. Anemia is shown to negatively affect autografted kidney function and actuarial survival i...

Full description

Bibliographic Details
Main Authors:	V. A. Goryainov, M. M. Kaabak, L. A. Shishlo, N. N. Babenko, M. M. Morozov
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:	Трансплантология (Москва)
Subjects:	renal transplantation posttransplantation anemia erythropoietin immunosuppression myelotoxicity
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/270

Similar Items

Generation of donor-specific immunotolerance in renal-allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Arterial hypertension in kidney transplant recipients: pathophysiology, diagnostics, treatment
by: M. Sh. Khubutiya, et al.
Published: (2024-06-01)

Azathioprine-induced marrow suppression in dermatology patients - Analysis of 18 patients
by: Vikrant V Saoji, et al.
Published: (2022-01-01)

Tuberculosis in kidney transplant recipients: A retrospective study from a tertiary care center - An observational study
by: Sujit Surendran, et al.
Published: (2022-01-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia
by: Akira Sezai, et al.
Published: (2023-03-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
by: Xiaomeng Zheng, et al.
Published: (2023-12-01)

Lipocalin-2, Soluble Transferrin Receptor, and Erythropoietin in Anemia During Mild Renal Dysfunction
by: Nahm CH, et al.
Published: (2023-08-01)

Extended Literature Review of the role of erythropoietin stimulating agents (ESA) use in the management of post renal transplant anaemia
by: Iman Alshamsi
Published: (2022-06-01)

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
by: Ni Made Hustrini, et al.
Published: (2019-11-01)

Epstein-Barr Viral Infection in Renal Allograft Recipients: A Single Center Experience
by: Zadeh Zakie, et al.
Published: (2006-01-01)

The use of belatacept in kidney transplantation
by: N. N. Babenko, et al.
Published: (2018-09-01)

Native Kidney Renal Cell Carcinoma in Renal Allograft Transplant Patients – Our Experience
by: Pavan Survase, et al.
Published: (2024-05-01)

Resistant cytomegalovirus infection in related donor kidney allograft recipients
by: V A Goryainov, et al.
Published: (2016-06-01)

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis
by: Wen-Yi Li, et al.
Published: (2008-11-01)

Bone marrow suppression and associated consequences in patients after heart transplantation: A 6-year retrospective review
by: Michal Pazdernik, et al.
Published: (2015-09-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
by: Dagmara Szypulska-Koziarska, et al.
Published: (2021-07-01)

Association of Erythropoietin, Adiponectin and Leptin levels with Anemia in uremic diabetic patients (Under hemodialysis):
by: Salim M. Al-Rubaâe, et al.
Published: (2011-01-01)

Real‐world experience: Introduction of T cell replete haploidentical transplantations in a single center
by: Gwendolyn vanGorkom, et al.
Published: (2021-08-01)

Factors Associated with Post-Transplant Anemia among Renal Transplant Recipients with Functioning Grafts in Sana’a City, Yemen
by: Arwa M. Othman, et al.
Published: (2017-11-01)

Factors Associated with Post-Transplant Anemia among Renal Transplant Recipients with Functioning Grafts in Sana’a City, Yemen
by: Arwa M. Othman, et al.
Published: (2017-11-01)

Erythropoietin in Cardiorenal Anemia Syndrome
by: Emir Fazlibegović, et al.
Published: (2008-11-01)

Refractory Giardiasis in a kidney transplant recipient
by: F. Yoonus, et al.
Published: (2021-02-01)

Safety of Weekly Single versus Divided Administration of Moderate-dose Erythropoietin in the Treatment of Maintenance Hemodialysis Patients with Renal Anemia
by: WU Xiuling, LI Jianjun, YU Ying, XING Rong, WANG Lu, WANG Xuedong, TENG Fubin
Published: (2023-02-01)

Effects of L-Carnitine Added to Erythropoietin in Anemic Chronic Renal Failure Patients on Hemodialysis.
by: N Taheri, et al.
Published: (2006-10-01)

Anemia Identified One Month after Renal Transplantation is Predictive of Anemia Identified After Twelve Months
by: Goran Imamović, et al.
Published: (2009-08-01)

ERYTHROPOIETIN TREATMENT FOR ANEMIA IN CHILDREN WITH CANCER – SINGLE CENTRE EXPERIENCES
by: Polona Mali, et al.
Published: (2004-12-01)

Erythropoietin levels in geriatric anemia
by: OV Fathima, et al.
Published: (2024-10-01)

VACCINATION OF CHILDREN WITH CHRONIC RENAL FAILURE IN PRE- AND POSTTRANSPLANTATION PERIODS
by: V. A. Goryainov, et al.
Published: (2013-11-01)

Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation
by: Yuewen Wang, et al.
Published: (2024-05-01)

The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01)

ORIGINAL PAPER<br> Erythropoietin therapy in chronic renal failure patients prior to hemodialysis
by: Jacek Rysz, et al.
Published: (2005-04-01)

Impact of erythropoietin on anemia in end-stage renal disease patients on hemodialysis
by: Bashaer M Muhammad-Baqir, et al.
Published: (2023-01-01)

Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01)

Anemia – an independent risk factor of adverse cardiovascular outcomes in women
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)

Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hypeferritinemia
by: Shahrbanoo Keyhanian, et al.
Published: (2008-01-01)

The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
by: Dae Woong Kang, et al.
Published: (2012-03-01)